These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Superior vena cava syndrome with bilateral jugular and subclavian vein thrombosis. Paraneoplastic manifestion of renal cell carcinoma]. May M; Seehafer M; Helke C; Uberrück T; Gunia S; Hoschke B Urologe A; 2003 Oct; 42(10):1374-7. PubMed ID: 14569387 [TBL] [Abstract][Full Text] [Related]
3. Progression of a caval vein thrombus in two patients with primary renal cell carcinoma on pretreatment with sunitinib. Bex A; Van der Veldt AA; Blank C; Meijerink MR; Boven E; Haanen JB Acta Oncol; 2010 May; 49(4):520-3. PubMed ID: 20105087 [No Abstract] [Full Text] [Related]
4. [A case of recurrent intracaval renal cell carcinoma effectively treated with sunitinib]. Komeya M; Matsumoto T; Fujinami K; Senga Y; Asakura T; Goto A Hinyokika Kiyo; 2010 Sep; 56(9):499-503. PubMed ID: 20940524 [TBL] [Abstract][Full Text] [Related]
12. Renal cell carcinoma invading the inferior vena cava: use of a "temporary" vena cava filter to prevent tumor emboli during nephrectomy. Wellons E; Rosenthal D; Schoborg T; Shuler F; Levitt A Urology; 2004 Feb; 63(2):380-2. PubMed ID: 14972500 [TBL] [Abstract][Full Text] [Related]
13. Superior vena cava syndrome caused by supraclavicular lymph node metastasis of renal cell carcinoma. Sakura M; Tsujii T; Yamauchi A; Tadokoro M; Tsukamoto T; Kawakami S; Yonese J; Fukui I Int J Clin Oncol; 2007 Oct; 12(5):382-4. PubMed ID: 17929122 [TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm. Shuch B; Riggs SB; LaRochelle JC; Kabbinavar FF; Avakian R; Pantuck AJ; Patard JJ; Belldegrun AS BJU Int; 2008 Sep; 102(6):692-6. PubMed ID: 18410444 [TBL] [Abstract][Full Text] [Related]
15. The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus. Cost NG; Delacroix SE; Sleeper JP; Smith PJ; Youssef RF; Chapin BF; Karam JA; Culp S; Abel EJ; Brugarolas J; Raj GV; Sagalowsky AI; Wood CG; Margulis V Eur Urol; 2011 Jun; 59(6):912-8. PubMed ID: 21367518 [TBL] [Abstract][Full Text] [Related]
16. Impact of surgery on the prognosis of metastatic renal cell carcinoma with IVC thrombus received TKI therapy. Kwon T; Lee JL; You D; Jeong IG; Song C; Ahn H; Kim CS; Hong JH J Surg Oncol; 2014 Aug; 110(2):145-50. PubMed ID: 24706355 [TBL] [Abstract][Full Text] [Related]
17. Presurgical sunitinib reduces tumor size and may facilitate partial nephrectomy in patients with renal cell carcinoma. Lane BR; Derweesh IH; Kim HL; O'Malley R; Klink J; Ercole CE; Palazzi KL; Thomas AA; Rini BI; Campbell SC Urol Oncol; 2015 Mar; 33(3):112.e15-21. PubMed ID: 25532471 [TBL] [Abstract][Full Text] [Related]
18. [Advanced sarcomatoid renal cell carcinoma effectively treated with sunitinib: report of a case]. Tsuchiyama K; Ito H; Ishida H; Itoh H; Yokoyama O Hinyokika Kiyo; 2011 Nov; 57(11):615-8. PubMed ID: 22166824 [TBL] [Abstract][Full Text] [Related]
19. Cytoreductive nephrectomy in metastatic clear-cell renal cell carcinoma: perspectives in the tyrosine kinase inhibitor era. Biswas S; Kelly J; Eisen T Oncologist; 2009 Jan; 14(1):52-9. PubMed ID: 19147692 [TBL] [Abstract][Full Text] [Related]
20. Rapid involution of choroidal metastasis secondary to renal cell carcinoma with oral sunitinib. Chin EK; Almeida DR; Sacher BA; Boldt HC JAMA Ophthalmol; 2015 Jan; 133(1):109-10. PubMed ID: 25321845 [No Abstract] [Full Text] [Related] [Next] [New Search]